Edition:
United Kingdom

Insulet Corp (PODD.OQ)

PODD.OQ on NASDAQ Stock Exchange Global Select Market

75.90USD
22 Jan 2018
Change (% chg)

$0.72 (+0.96%)
Prev Close
$75.18
Open
$75.25
Day's High
$76.14
Day's Low
$74.91
Volume
95,132
Avg. Vol
189,723
52-wk High
$78.56
52-wk Low
$38.43

Latest Key Developments (Source: Significant Developments)

Ascensia Diabetes Care Enters Strategic Alliance With Insulet Corp
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - ASCENSIA DIABETES CARE::ASCENSIA DIABETES CARE EXPANDS STRATEGIC ALLIANCE WITH INSULET CORPORATION BY SIGNING COMMERCIAL AGREEMENT.ASCENSIA DIABETES CARE - RECIPIENTS OF OMNIPOD DASH WILL RECEIVE CONTOURNEXT ONE METER, CONTOUR NEXT TEST STRIPS PACKAGED WITH INSULIN PUMP.ASCENSIA DIABETES CARE - UNDER TERMS OF NON-EXCLUSIVE COMMERCIAL AGREEMENT, INSULET WILL DISTRIBUTE CONTOUR NEXT ONE BGMS WITH OMNIPOD DASH.  Full Article

Insulet announces pricing of convertible senior notes due 2024
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Insulet Corp :Insulet announces pricing of convertible senior notes due 2024.Insulet Corp - ‍priced a private placement of $350 million principal amount of convertible senior notes due 2024​.Insulet Corp - ‍size of offering increased from previously announced $300 million principal amount​.  Full Article

Insulet announces private offering of convertible senior notes
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Insulet Corp :Insulet announces private offering of convertible senior notes.Insulet Corp says ‍to offer $300 million principal amount of convertible senior notes due 2024 in a private placement​.Insulet - ‍intends to grant initial purchasers of notes option to buy up to an additional $45 million principal amount of notes​.  Full Article

Insulet Corp reports Q3 loss per share $0.04
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Insulet Corp :Insulet reports third quarter 2017 financial results.Q3 loss per share $0.04.Q3 revenue $121.8 million versus I/B/E/S view $114.4 million.Q3 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S.Sees fy 2017 revenue up 25 percent.Sees fy 2017 revenue $456 million to $459 million.  Full Article

Insulet announces private offering of convertible senior notes
Tuesday, 6 Sep 2016 

Insulet Corp : Insulet announces private offering of convertible senior notes .Insulet Corp says to offer $250 million principal amount of convertible senior notes due 2021 (notes) in a private placement.  Full Article

Insulet Corp reports Q2 loss per share of $0.08 from cont ops
Wednesday, 3 Aug 2016 

Insulet Corp : Insulet reports second quarter 2016 financial results . Q2 loss per share $0.08 from continuing operations . Q2 revenue $87.3 million versus I/B/E/S view $81.2 million . Q2 earnings per share view $-0.17 -- Thomson Reuters I/B/E/S . Sees revenue guidance for 2016 in range of $345 to $355 million .FY2016 revenue view $337.4 million -- Thomson Reuters I/B/E/S.  Full Article

Insulet Corp reaffirms FY 2016 revenue guidance; gives Q2 2016 revenue guidance
Thursday, 28 Apr 2016 

Insulet Corp:For FY 2016, the Company is reaffirming its revenue guidance of $330 to $350 million.For Q2 2016, the Company is introducing revenue guidance in the range of $81 to $84 million.  Full Article

Insulet Corp announces development partner for the omnipod artificial pancreas
Thursday, 25 Feb 2016 

Insulet Corp:License agreement and partnership with Mode AGC to develop and incorporate advanced artificial pancreas algorithm created by renowned researchers Francis Doyle PhD, Eyal Dassau PhD, and Howard Zisser MD.  Full Article

BRIEF-Ascensia Diabetes Care Enters Strategic Alliance With Insulet Corp

* ASCENSIA DIABETES CARE EXPANDS STRATEGIC ALLIANCE WITH INSULET CORPORATION BY SIGNING COMMERCIAL AGREEMENT